Eversept Partners, LP Glaukos Corp Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
A detailed history of Eversept Partners, LP transactions in Glaukos Corp stock. As of the latest transaction made, Eversept Partners, LP holds 158,957 shares of GKOS stock, worth $14.7 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
158,957Holding current value
$14.7 Million% of portfolio
1.73%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
358Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$745 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$553 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$212 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$184 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$180 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.41B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...